New Indian patent law could mean more attention to neglected diseases

01/5/2005 | Business Standard (India)

India's new patent law means hope for more innovation to produce drugs for treating neglected diseases, according to the head of an organization dedicated to the subject. India accounts for 1.8% of the world's estimated $406 billion pharmaceutical market, he said, but only 1% of India's production is for neglected diseases. With the new patent law, Indian drugmakers will have to develop new drugs and delivery systems, the executive director of the group said, adding that much of it should be centered on neglected diseases.

View Full Article in:

Business Standard (India)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Abbott
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA